Drawing for FRAGMA

USPTO serial 98632314

FRAGMA

Reviewed by CopyMark Law Group

Reg. 8055635Status 700Registered
Filing date
Status date
Registration date
Dec 9, 2025
Examiner
NEAL, KELLY L
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with FRAGMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

R. Glenn Schroeder

R. Glenn Schroeder Schroeder Law PC110 Cooper Street #605Babylon, NY 11702United States

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in industry and science; assays and reagents for scientific and research use; diagnostic reagents and preparations for scientific use; diagnostic test kits consisting primarily of nucleic acids testing reagents for use in the fields of scientific research; chemical reagents for non-medical purposes; chemical preparations for testing and analyzing nucleic acids for scientific and medical research use; chemical reagents for scientific purposes; reagents, enzymes, and nucleotides for medical research useACTIVE—
005Pharmaceutical, medical and veterinary preparations for the treatment of cancer, pregnancy-associated conditions, prenatal conditions, transplantation-related conditions, chronic disorders and inflammatory conditions; medical diagnostic reagents; diagnostic reagents for medical or veterinary purposes; reagents, enzymes, and nucleotides for use in cancer, nucleic acid, genetic, epigenetic and genomic testing for medical and diagnostic purposes; diagnostic test reagents for medical purposes; diagnostic test reagents for medical purposes for determination of cancer and biomolecule, nucleic acid, genetic, epigenetic and genomic information; pharmaceutical products for the treatment of cancer, pregnancy-associated conditions, prenatal conditions, transplantation-related conditions, chronic disorders and inflammatory conditions; diagnostic medical reagents for medical use; medical diagnostic test kits comprised of reagents and assays for testing of body fluidsACTIVE—
009Scientific, surveying, optical, weighing and measuring apparatus and instruments, namely, nucleic acids analysis instruments; apparatus for recording, transmission or reproduction of sound and images; data processing equipment and computers; downloadable computer operating programs and computer operating systems; downloadable computer software for use in connecting networks and disparate computer systems, computer servers and storage devices; cloud servers, namely, computer servers, network servers, and computer network services all for use in cloud computing; downloadable computer software for cloud computing, namely, software for deploying virtual machines to a cloud computing platform and managing virtual machines on a cloud computing platform; downloadable computer software platforms for cloud computing networks and applications; automated laboratory apparatus, namely, nucleic acid extraction instruments and sequencers for use in analysis of biomolecules; computer hardware and recorded software systems for remotely controlling and monitoring automated laboratory apparatuses in the nature of nucleic acid extraction instruments and sequencers; computer hardware and recorded software systems for use in analysis of cancers, biomolecules, nucleic acids, genetics, epigenetics and genomics; downloadable computer software for scientific analysis of genetic sequences; cancer genome, biomolecule, nucleic acid, genetic, epigenetic and genomic sequencers for scientific purpose; laboratory equipment, namely, nucleic acids analysis instruments; medical laboratory research instruments for use in genetic and disease testing; nuclear medical research imaging apparatus; magnetic resonance imaging apparatus, not for medical purposes; non-medical imaging devices for use in genetic and disease testing; downloadable computer software for data collection, management, and analysis of cancer, biomolecule, nucleic acid, genetic, epigenetic and genomic information for use in the field of diagnostic and clinical research, and for clinical diagnostic purposes and scientific research; downloadable computer software for use in database management; scientific measuring apparatus and instruments, namely, nucleic acids analysis instruments; scientific laboratory research instruments for detecting pathogens; scientific equipment and instruments, namely, nucleic acids analysis instruments; pre-recorded optical discs featuring medical reports, machine-readable; pre-recorded magnetic discs featuring medical reports, machine-readable; biotechnology related downloadable software for nucleic acids analysis, cancer, biomolecule, genetic, epigenetic and genomic testing apparatus and instruments; downloadable computer biotechnology software for data collection, management, and analysis of genetic information for use in the field of diagnostic and clinical research and for clinical diagnostic purposes and scientific research; diagnostic apparatus for research laboratory use for cancer, biomolecule, nucleic acid, genetic, epigenetic and genomic testing, not for medical purposesACTIVE—
010Diagnostic apparatus for medical purposes for genetic and disease testing; automatic analysis medical apparatus for testing blood, urine and other tissue samples; medical apparatus for use in blood, urine and tissue collecting; surgical apparatus and instruments for medical use; medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancerACTIVE—
035Collection, compilation and systemization of information into a computer database; compilation of statistics; administrative data processing services; office functions in the nature of searching for data in computer files for others; computerised file management; product demonstrations; organisation of events, exhibitions, fairs and shows for commercial, promotional and advertising purposes; business consultancy, business advisory services; business management; business administration; business administrative services and business consultancy; market research; marketing research; conducting marketing studiesACTIVE—
042Scientific research and development; scientific research; medical research; research and development in the field of cancer, biomolecules, nucleic acids, genetics, epigenetics, and genomic testing for scientific research purposes; scientific and technological services, namely, diagnostic services, reagent testing, analysis, and testing in the field of scientific research related to cancer, biomolecules, nucleic acids, genetics, epigenetics, and genomic testing; technological research in the field of biotechnology, medical diagnostics, and scientific testing methods; research and development services in the field of biotechnology; providing medical testing services and information in the field of cancer research and disease classification; providing reagent sample testing and diagnostic services for others for scientific research purposes; research and development services in the field of diagnostic preparations; computer services namely, computer programming services and computer modelling services, in the fields of bioinformatics, and medical informatics; design and development of computer hardware and software; cloud storage services for electronic data that enables users to store, analyze and share data in the fields of life science; technical support services, namely, troubleshooting of computer software problems; scientific research consulting services in the field of medical diagnostics, genomics and bioinformatics; providing online non-downloadable software for the custom design and ordering of assays and reagents; laboratory research in the field of cancers, biomolecules, nucleic acids, genetics, epigenetics and genomics; design and development of laboratory apparatus and instruments and computer systems for use in analysis of cancers, biomolecules, nucleic acids, genetics, epigenetics and genomics; designing of machines, apparatus, instruments including their parts or systems composed of such machines, apparatus and instruments for use in analysis of cancers, biomolecules, nucleic acids, genetics, epigenetics and genomics; design of mechanical, electromechanical and optoelectronic apparatus and instruments for use in analysis of cancers, biomolecules, nucleic acids, genetics, epigenetics and genomics; design and development of on-line computer software system for use in analysis of cancers, biomolecules, nucleic acids, genetics, epigenetics and genomics; design and development of computer software for collection, management, and analysis of genetic information for use in analysis of cancers, biomolecules, nucleic acids, genetics, epigenetics and genomics; computer system design services for use in analysis of cancers, biomolecules, nucleic acids, genetics, epigenetics and genomics; installation and maintenance of computer software used in the field of analysis of biomolecules, cancers, nucleic acids, epigenetics and genomics; scientific research consulting in the field of cancers, biomolecules, nucleic acids, genetics, epigenetics and genomics; consultancy, information and advisory services in the field of analysis of biomolecules, cancers, nucleic acids, genetics, epigenetics and genomics; product development in the fields of scientific and clinical research; product research and development services for others in the field of chemicals and reagents for use as diagnostics, and other utilities, and chemical screening and diagnostic services for others; product research and development services for others, and product design and development for others, all in the field of pharmaceuticals, diagnostic and health care products; design and testing of new products for others in the field of diagnostic and health care products; database development services; design and development of medical diagnostic apparatus and instruments and on-line computer software systems for use in analysis of biomolecules, cancers, nucleic acids, genetics, epigenetics and genomics; chemical screening analysis; product design and development in the field of medical diagnostic apparatus and instruments and on-line computer software systems for use in analysis of cancers, biomolecules, nucleic acids, genetics, epigenetics and genomics; product research and development services for others in the field of chemical reagents and reagents for use as diagnostics, therapeutics, herbicides, cytotoxic agents, and other utilities, and chemical screening and diagnostic services for others; product design and development in the field of diagnostic, pharmaceutical and health care products; research and development in the field of diagnostic preparations, pharmaceutical products and health care products; providing on-line non-downloadable computer software for scientific analysis of genetic sequences; providing on-line non-downloadable computer software for scientific analysis of cancer, biomolecule, nucleic acid, genetic, epigenetic and genomic sequencing; rental of computers; rental of computer software for use in analysis of biomolecules; rental of computer hardware and computer peripheralsACTIVE—
044Medical services; veterinary services; health care; medical diagnostic testing and reporting services; medical diagnostic services; veterinary analysis services for diagnostic and treatment purposes provided by veterinary laboratories and medical analysis services for diagnostic and treatment purposes provided by medical laboratories in the nature of preparing, amplifying, labeling, detecting, analyzing and sequencing of cancers, biomolecules, nucleic acids, genetics, epigenetics and genomics from human beings and animals; medical testing services; genetic testing for medical purposes; medical testing for diagnostic or treatment purposes; genetic testing of animals for diagnostic or treatment purposes; medical screening services in the field of cancer and pregnancy-associated conditions, prenatal conditions, transplantation-related conditions, chronic disorders and inflammatory conditions; Immunochemical medical diagnostic testing services for detecting and measuring antibody levels; medical screening; medical diagnostic testing, monitoring and reporting services; genetic testing for cancer risk for medical purposes; DNA screening for medical purposes; cancer screening servicesACTIVE—
045Licensing of patents, trademarks, software, copyright and intellectual property rights; monitoring of intellectual property rights for legal advisory purposes; leasing of internet domain names; rental of internet domain namesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 9, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 9, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 21, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 21, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 15, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 18, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 17, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Sep 17, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 17, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 17, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 30, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 30, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 30, 2025ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Aug 24, 2025D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Jun 2, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 2, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 2, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 11, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 11, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 11, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 25, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 25, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 25, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 22, 2025DOCKASSIGNED TO EXAMINER—
Jan 14, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 3, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance